China Has $14 Billion Worth of Pharma-Bio Projects in Planning, an Industrial Info Market Brief
China Has $14 Billion Worth of Pharma-Bio Projects in Planning, an Industrial Info Market Brief
Attachment: China pharma 0620
Industrial Info is tracking 277 active projects in China's Pharmaceutical & Biotech Industry, worth $13.6 billion, that are in the planning stage. Jiangsu leads the provinces with 34 projects.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021